Skip to main content

Sofía Vila-Sanjuán Zamora

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Sofía Vila-Sanjuán Zamora

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Toxicitat cardiovascular en el càncer de mama HER 2-positiu precoç: desde l'avaluació del risc fins a la prevenció

IP: Ignacio Ferreira González
Collaborators: José Antonio Barrabés Riu, José Raul Herance Camacho, Gerard Oristrell Santamaria, Javier Limeres Freire, Raul Aguilar Lopez, Filipa Xavier De Carvalho Negrao Valente, Sofía Vila-Sanjuán Zamora, Nuria Coma Auli
Funding agency: Fundació La Marató de TV3
Funding: 198125
Reference: 202311-10
Duration: 11/03/2024 - 10/03/2027

Related news

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

In light of this evidence, hospitals such as Vall d'Hebron have already started to include warnings about environmental pollution in their hospital discharge plans after a myocardial infarction.

Related professionals

Sandra Luis Pina

Sandra Luis Pina

Infectious Diseases
Read more
Vicente García-Patos Briones

Vicente García-Patos Briones

Head of group
Biomedical Research in Melanoma
Read more
Juliana Esperalba Esquerra

Juliana Esperalba Esquerra

Research technician
Microbiology
Read more
Maria Cristina Centeno Mediavilla

Maria Cristina Centeno Mediavilla

Biomedical Research in Gynaecology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.